產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-C6orf52抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-C6orf52抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C6orf52
Cat. Number:
Anti-C6orf52抗體KL-15248R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated Anti-C6orf52抗體with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf52 gene product has been provisionally designated C6orf52 pending further characterization.
Also known as:
chromosome 6 open Anti-C6orf52抗體reading frame 52; putative uncharacterized protein C6orf52;CF052_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .Anti-C6orf52抗體
●
Immunogen: KLH conjugated synthetic peptide derived from human C6orf52.
●
Predicted Molecular Weight: 17kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-C6orf52抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl337Mu02 彈性蛋白(ELN)多克隆抗體 Polyclonal Antibody to Elastin (ELN)
kl343Bo01 Bcl2關(guān)聯(lián)X蛋白(Bax)多克隆抗體 Polyclonal Antibody to Bcl2 Associated X Protein (Bax)
kl343Mu02 Bcl2關(guān)聯(lián)X蛋白(Bax)多克隆抗體 Polyclonal Antibody to Bcl2 Associated X Protein (Bax)
kl344Hu01 平滑肌肌動(dòng)蛋白γ2(ACTγ2)多克隆抗體 Polyclonal Antibody to Actin Gamma 2, Smooth Muscle (ACTg2)
kl345Mu02 四旋蛋白30(TSkl30)多克隆抗體 Polyclonal Antibody to Tetrasklin 30 (TSkl30)
kl347Mu02 垂體腺苷酸環(huán)化酶激活肽(ADCYAP1)多克隆抗體 Polyclonal Antibody to Adenylate Cyclase Activating Polypeptide 1, Pituitary (ADCYAP1)
kl361Mu01 ****擴(kuò)張性共濟(jì)失調(diào)突變因子(ATM)多克隆抗體 Polyclonal Antibody to Ataxia Telangiectasia Mutated (ATM)
kl361Mu02 ****擴(kuò)張性共濟(jì)失調(diào)突變因子(ATM)多克隆抗體 Polyclonal Antibody to Ataxia Telangiectasia Mutated (ATM)
kl364Mu02 乳腺癌易感蛋白2(BRCA2)多克隆抗體 Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
kl366Mu02 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
kl366Ra01 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
kl367Mu02 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl367Po01 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl373Bo01 防御素β1(DEFβ1)多克隆抗體 Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl373Mu02 防御素β1(DEFβ1)多克隆抗體 Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl375Hu02 γ-谷氨酰轉(zhuǎn)移酶1(γGT1)多克隆抗體 Polyclonal Antibody to Gamma-Glutamyltransferase 1 (gGT1)
kl375Mu02 γ-谷氨酰轉(zhuǎn)移酶1(γGT1)多克隆抗體 Polyclonal Antibody to Gamma-Glutamyltransferase 1 (gGT1)
kl385Ra01 轉(zhuǎn)錄激活因子4(ATF4)多克隆抗體 Polyclonal Antibody to Activating Transcription Factor 4 (ATF4)
